Basic Information
| Terpenoid ID | TKC206672 |
|
| Chirality | TKC109623 | |
| Cell line | 0 | |
| Protein target | 19 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 111 |
| Terpenoid ID | TKC206672 |
|
| Chirality | TKC109623 | |
| Cell line | 0 | |
| Protein target | 19 | |
| DiseaseNCIT | 0 | |
| ORDO | 0 | |
| ICD | 111 |
| ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
|---|---|---|---|---|---|---|---|
| TKC206672 | Lymphoblastoid cells | 12589.0 | nM | Potency | |||
| TKC206672 | HepG2 | 6310.0 | nM | Potency | C3728 | Orphanet_449 | |
| TKC206672 | MDA-N | MDAN | 42170.0 | nM | GI50 | C3802 | |
| TKC206672 | SN12C | SN-12C | 34041.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC206672 | ACHN | 37844.0 | nM | GI50 | C6975 | Orphanet_319298 | |
| TKC206672 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 39719.0 | nM | GI50 | C3512 | |
| TKC206672 | UO-31 | UO.31; UO31; U031 | 37584.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC206672 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 30061.0 | nM | GI50 | C9154 | Orphanet_519 |
| TKC206672 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 65615.0 | nM | GI50 | C4863 | |
| TKC206672 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 47973.0 | nM | GI50 | C3796 | Orphanet_251576 |
| TKC206672 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 37844.0 | nM | GI50 | C3510 | |
| TKC206672 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 32810.0 | nM | GI50 | C3224 | |
| TKC206672 | K562 | K562; K.562; K 562; KO; GM05372; GM05372E | 36559.0 | nM | GI50 | C9110 | Orphanet_521 |
| TKC206672 | A498 | A498 | 41210.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC206672 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 20370.0 | nM | GI50 | C105555 | |
| TKC206672 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 26546.0 | nM | GI50 | C9142 | Orphanet_99861 |
| TKC206672 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 26363.0 | nM | GI50 | C3512 | |
| TKC206672 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 44463.0 | nM | GI50 | C105555 | |
| TKC206672 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 30690.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC206672 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 39355.0 | nM | GI50 | C105555 | |
| TKC206672 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 44668.0 | nM | GI50 | C105555 | |
| TKC206672 | MDA-MB-231 | MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 | 41495.0 | nM | GI50 | C5214 | |
| TKC206672 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 40087.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC206672 | TK-10 | TK.10; TK 10; TK10 | 100000.0 | nM | GI50 | C4033 | Orphanet_319276 |
| TKC206672 | SW-620 | SW-620; SW 620; SW.620 | 47753.0 | nM | GI50 | C4349 | |
| TKC206672 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 27990.0 | nM | GI50 | C3512 | |
| TKC206672 | KM12 | KM-12; KM.12 | 49431.0 | nM | GI50 | C4910 | |
| TKC206672 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 43652.0 | nM | GI50 | C2923 | |
| TKC206672 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 34277.0 | nM | GI50 | C3802 | |
| TKC206672 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 25823.0 | nM | GI50 | C3242 | Orphanet_29073 |
| TKC206672 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 49659.0 | nM | GI50 | C105555 | |
| TKC206672 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 40832.0 | nM | GI50 | C3802 | |
| TKC206672 | BT-549 | BT 549; BT.549; BT549 | 48417.0 | nM | GI50 | C4194 | |
| TKC206672 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 31189.0 | nM | GI50 | C3224 | |
| TKC206672 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 61235.0 | nM | GI50 | C4349 | |
| TKC206672 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 37068.0 | nM | GI50 | C3058 | Orphanet_360 |
| TKC206672 | HCT-15 | HCT-15; HCT.15; HCT15 | 36141.0 | nM | GI50 | C4349 | |
| TKC206672 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 32885.0 | nM | GI50 | C4910 | |
| TKC206672 | SF-268 | SF-268; SF.268; SF 268 | 40087.0 | nM | GI50 | C60781 | Orphanet_94 |
| TKC206672 | EKVX | 31405.0 | nM | GI50 | C3512 | ||
| TKC206672 | PC-3 | PC3; PC.3 | 33574.0 | nM | GI50 | C4863 | |
| TKC206672 | MCF7 | 36224.0 | nM | GI50 | C4194 | ||
| TKC206672 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 26730.0 | nM | GI50 | C7978 | |
| TKC206672 | T47D | 31405.0 | nM | GI50 | C4194 | ||
| TKC206672 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 40738.0 | nM | GI50 | C4450 | |
| TKC206672 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 69502.0 | nM | GI50 | C3224 | |
| TKC206672 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 37497.0 | nM | GI50 | C3224 | |
| TKC206672 | SF-295 | SF-295; SF.295; SF 295 | 17783.0 | nM | GI50 | C3058 | Orphanet_360 |
| TKC206672 | MDA-MB-435 | MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 | 42170.0 | nM | GI50 | C3802 | |
| TKC206672 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 27925.0 | nM | GI50 | C7979 | Orphanet_454723 |
| TKC206672 | Hs-578T | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells | 40738.0 | nM | GI50 | C4194 | |
| TKC206672 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 45814.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC206672 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 92257.0 | nM | GI50 | C3224 | |
| TKC206672 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 23933.0 | nM | GI50 | C7953 | Orphanet_99861 |
| TKC206672 | HT-29 | HT 29; HT29 | 34119.0 | nM | GI50 | C4349 | |
| TKC206672 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 95060.0 | nM | GI50 | C45662 | Orphanet_50251 |
| TKC206672 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 63096.0 | nM | GI50 | C3510 | |
| TKC206672 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 52360.0 | nM | GI50 | C9385 | Orphanet_217071 |
| TKC206672 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 27861.0 | nM | GI50 | C4349 | |
| TKC206672 | HuTu80 | HUTU 80; Hutu 80; HuTu-80; HUTU-80; Hutu-80; HUTU80; HuTu80; Hutu80 | 82900.0 | nM | IC50 | C7889 |
| ID | Uniport | Pref_name | Gene name | value | unit | type |
|---|---|---|---|---|---|---|
| TKC206672 | P11473 | Vitamin D3 receptor | VDR | >50000 | nM | IC50 |
| TKC206672 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 33498 | nM | Potency |
| TKC206672 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 97 | % | Inhibition |
| TKC206672 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 83 | % | Inhibition |
| TKC206672 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 66824 | nM | Potency |
| TKC206672 | O75496 | Geminin | GMNN | 73 | nM | Potency |
| TKC206672 | O89049 | Thioredoxin reductase 1, cytoplasmic | Txnrd1 | 89125 | nM | Potency |
| TKC206672 | Q13148 | TAR DNA-binding protein 43 | TARDBP | 35481 | nM | Potency |
| TKC206672 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | PIN1 | 25119 | nM | Potency |
| TKC206672 | P04150 | Glucocorticoid receptor | NR3C1 | 50119 | nM | Potency |
| TKC206672 | P0DTD1 | Replicase polyprotein 1ab | rep | 16 | % | Inhibition |
| TKC206672 | P83916 | Chromobox protein homolog 1 | CBX1 | 89125 | nM | Potency |
| TKC206672 | P25779 | Cruzipain | 15849 | nM | Potency | |
| TKC206672 | P37231 | Peroxisome proliferator-activated receptor gamma | PPARG | 31623 | nM | Potency |
| TKC206672 | Q03181 | Peroxisome proliferator-activated receptor delta | PPARD | 17783 | nM | Potency |
| TKC206672 | P78417 | Glutathione S-transferase omega-1 | GSTO1 | 1020000 | nM | IC50 |
| TKC206672 | P19793 | Retinoic acid receptor RXR-alpha | RXRA | 28184 | nM | Potency |
| TKC206672 | P51449 | Nuclear receptor ROR-gamma | RORC | 42163 | nM | Potency |
| TKC206672 | O95342 | Bile salt export pump | ABCB11 | 65 | % | Activity |
| TKC206672 | Q96RI1 | Bile acid receptor | NR1H4 | 45000 | nM | EC50 |
| TKC206672 | Q8TDU6 | G-protein coupled bile acid receptor 1 | GPBAR1 | 4390 | nM | EC50 |
| TKC206672 | Q12908 | Ileal sodium/bile acid cotransporter | SLC10A2 | 6300 | nM | Ki |
| TKC206672 | Q9HYR3 | Uncharacterized PhzA/B-like protein PA3332 | PA3332 | 44500 | nM | Kd |
| TKC206672 | P07445 | Steroid Delta-isomerase | ksi | 16000 | nM | Kd |
| Uniport ID | Uniport Name | ICD-11 |
|---|---|---|
| P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
| P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
| P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
| P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
| P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
| P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
| P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
| P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
| P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
| P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
| P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
| P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
| P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
| Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
| Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
| Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
| Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
| Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
| Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
| Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
| Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
| Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
| Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
| Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
| Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
| Q13148 | TADBP_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
| Q13148 | TADBP_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| Q13526 | PIN1_HUMAN | Lung cancer [ICD-11: 2C25] |
| Q13526 | PIN1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
| P04150 | GCR_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
| P04150 | GCR_HUMAN | Indeterminate colitis [ICD-11: DD72] |
| P04150 | GCR_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
| P04150 | GCR_HUMAN | Muscular dystrophy [ICD-11: 8C70] |
| P04150 | GCR_HUMAN | Prostate cancer [ICD-11: 2C82] |
| P04150 | GCR_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
| P04150 | GCR_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P04150 | GCR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P04150 | GCR_HUMAN | Adaptive immunity immunodeficiency [ICD-11: 4A01] |
| P04150 | GCR_HUMAN | Adrenogenital disorder [ICD-11: 5A71] |
| P04150 | GCR_HUMAN | Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
| P04150 | GCR_HUMAN | Asthma [ICD-11: CA23] |
| P04150 | GCR_HUMAN | Atopic eczema [ICD-11: EA80] |
| P04150 | GCR_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
| P04150 | GCR_HUMAN | Cushing syndrome [ICD-11: 5A70] |
| P04150 | GCR_HUMAN | Eczema [ICD-11: EA80-EA89] |
| P04150 | GCR_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
| P04150 | GCR_HUMAN | Muscular dystrophy [ICD-11: 8C70] |
| P04150 | GCR_HUMAN | Oesophagitis [ICD-11: DA24] |
| P04150 | GCR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
| P04150 | GCR_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
| P04150 | GCR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P04150 | GCR_HUMAN | Spine/trunk injury [ICD-11: ND51] |
| P04150 | GCR_HUMAN | Vasomotor/allergic rhinitis [ICD-11: CA08] |
| P04150 | GCR_HUMAN | Herpes simplex infection [ICD-11: 1F00] |
| P04150 | GCR_HUMAN | Otitis externa [ICD-11: AA00-AA13] |
| P04150 | GCR_HUMAN | Substance abuse [ICD-11: 6C40] |
| P04150 | GCR_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| P04150 | GCR_HUMAN | Depression [ICD-11: 6A70-6A7Z] |
| P04150 | GCR_HUMAN | Mood disorder [ICD-11: 6A60-6E23] |
| P04150 | GCR_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P04150 | GCR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
| P04150 | GCR_HUMAN | Retinopathy [ICD-11: 9B71] |
| P04150 | GCR_HUMAN | Anxiety disorder [ICD-11: 6B00-6B0Z] |
| P25779 | CYSP_TRYCR | Parasitic worm infestation [ICD-11: 1F90] |
| P25779 | CYSP_TRYCR | Malaria [ICD-11: 1F40-1F45] |
| P37231 | PPARG_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
| P37231 | PPARG_HUMAN | Sjogren syndrome [ICD-11: 4A43] |
| P37231 | PPARG_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P37231 | PPARG_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
| P37231 | PPARG_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| P37231 | PPARG_HUMAN | Obesity [ICD-11: 5B80-5B81] |
| P37231 | PPARG_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| P37231 | PPARG_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
| P37231 | PPARG_HUMAN | Glaucoma [ICD-11: 9C61] |
| P37231 | PPARG_HUMAN | Inborn lipid metabolism error [ICD-11: 5C52] |
| P37231 | PPARG_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P37231 | PPARG_HUMAN | Gout [ICD-11: FA25] |
| P37231 | PPARG_HUMAN | Indeterminate colitis [ICD-11: DD72] |
| P37231 | PPARG_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
| P37231 | PPARG_HUMAN | Nicotine use disorder [ICD-11: 6C4A] |
| P37231 | PPARG_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| P37231 | PPARG_HUMAN | Opioid use disorder [ICD-11: 6C43] |
| P37231 | PPARG_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
| P37231 | PPARG_HUMAN | Idiopathic interstitial pneumonitis [ICD-11: CB03] |
| P37231 | PPARG_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
| Q03181 | PPARD_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| Q03181 | PPARD_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| Q03181 | PPARD_HUMAN | Autoimmune liver disease [ICD-11: DB96] |
| Q03181 | PPARD_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
| Q03181 | PPARD_HUMAN | Obesity [ICD-11: 5B80-5B81] |
| Q03181 | PPARD_HUMAN | Alzheimer disease [ICD-11: 8A20] |
| Q03181 | PPARD_HUMAN | Dyslipidemia [ICD-11: 5C80-5C81] |
| Q03181 | PPARD_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
| Q03181 | PPARD_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
| Q03181 | PPARD_HUMAN | Central nervous system disease [ICD-11: 8A04-8D87] |
| P78417 | GSTO1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P19793 | RXRA_HUMAN | Kaposi sarcoma [ICD-11: 2B57] |
| P19793 | RXRA_HUMAN | Mycosis fungoides [ICD-11: 2B01] |
| P51449 | RORG_HUMAN | Autoimmune disease [ICD-11: 4A40-4A45] |
| P51449 | RORG_HUMAN | Lung cancer [ICD-11: 2C25] |
| P51449 | RORG_HUMAN | Psoriasis [ICD-11: EA90] |
| P51449 | RORG_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
| P51449 | RORG_HUMAN | Crohn disease [ICD-11: DD70] |
| P51449 | RORG_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
| P51449 | RORG_HUMAN | Arterial occlusive disease [ICD-11: BD40] |
| P51449 | RORG_HUMAN | Liver cancer [ICD-11: 2C12] |
| P51449 | RORG_HUMAN | Rheumatoid arthritis [ICD-11: FA20] |
| Q96RI1 | NR1H4_HUMAN | Autoimmune liver disease [ICD-11: DB96] |
| Q96RI1 | NR1H4_HUMAN | Cholelithiasis [ICD-11: DC11] |
| Q96RI1 | NR1H4_HUMAN | Insomnia [ICD-11: 7A00-7A0Z] |
| Q96RI1 | NR1H4_HUMAN | Osteoarthritis [ICD-11: FA00-FA05] |
| Q96RI1 | NR1H4_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
| Q96RI1 | NR1H4_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
| Q96RI1 | NR1H4_HUMAN | Chronic kidney disease [ICD-11: GB61] |
| Q96RI1 | NR1H4_HUMAN | Skeletal anomaly [ICD-11: LD24] |
| Q96RI1 | NR1H4_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
| Q96RI1 | NR1H4_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
| Q96RI1 | NR1H4_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| Q8TDU6 | GPBAR_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
| Q8TDU6 | GPBAR_HUMAN | Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
| Q8TDU6 | GPBAR_HUMAN | Metabolic disorder [ICD-11: 5C50-5D2Z] |
| Q12908 | NTCP2_HUMAN | Gallbladder/bile ducts/liver structural developmental anomaly [ICD-11: LB20] |
| Q12908 | NTCP2_HUMAN | Inborn lipid metabolism error [ICD-11: 5C52] |
| Q12908 | NTCP2_HUMAN | Inborn porphyrin/heme metabolism error [ICD-11: 5C58] |
| Q12908 | NTCP2_HUMAN | Autoimmune liver disease [ICD-11: DB96] |
| Q12908 | NTCP2_HUMAN | Hyper-lipoproteinaemia [ICD-11: 5C80] |
| Q12908 | NTCP2_HUMAN | Pruritus [ICD-11: EC90] |
| Q12908 | NTCP2_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |